The Association of ACSL1 and UCP2 3′ UTR Polymorphisms With the Clinicopathological Characteristics of Patients With Colorectal Cancer in Serbia
References
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2024;74(3):229–263.
- Pakiet A, Kobiela J, Stepnowski P, Sledzinski T, Mika A. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids in health and disease. 2019;18(1):29.
- Miyo M, Konno M, Nishida N, Sueda T, Noguchi K, Matsui H, et al. Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer. Scientific Reports. 2016;6:38415.
- Aguilar E, Esteves P, Sancerni, T, Lenoir V, Aparicio T, Bouillaud F, et al. UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses. Cell reports. 2019;28(9):2306–2316.e5.
- Chen WC, Wang CY, Hung YH, Weng TY, Yen, MC, Lai MD (2016) Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer. PloS one 11(5): e0155660.
https://doi.org/10.1371/journal.pone.0155660 - Cucchi D, Camacho-Muñoz D, Certo M, Pucino V, Nicolaou A, Mauro C. Fatty acids - from energy substrates to key regulators of cell survival, proliferation and effector function. Cell stress. 2019;4(1): 9–23.
- Zhang L, Wang X. Characteristics of long-chain acyl-CoA synthetases in metabolism and cancer. Clin Transl Disc. 2023;3:e200.
- Tang Y, Zhou J, Hooi SC, Jiang YM, Lu GD. Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases. Oncology letters. 2018;16(2): 1390–1396.
- Ellis JM, Frahm JL, Li LO, Coleman RA. Acyl-co-enzyme A synthetases in metabolic control. Current opinion in lipidology. 2010;21(3): 212–217.
- Rossi Sebastiano M, Konstantinidou G. Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy. International journal of molecular sciences. 2019;20(15): 3624.
- Quan J, Bode AM, Luo X. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. European journal of pharmacology. 2021;909:174397.
- Vargas T, Moreno-Rubio J, Herranz J, Cejas P, Molina S, Mendiola M, et al. 3′UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients. PloS one. 2016; 11(12):e0168423.
- Storz P. Reactive oxygen species in tumor progression. Frontiers in bioscience. 2005;10:1881–1896.
- Horimoto M, Resnick MB, Konkin TA, Routhier J, Wands JR, Baffy G. Expression of uncoupling protein-2 in human colon cancer. Clinical cancer research. 2004;10:6203–6207.
- Diano S, Horvath TL. Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism. Trends in molecular medicine. 2012;18(1): 52–58.
- Kaabi YA, Mansor AS, Alfagih AS, Hakami AM, Summ MA, Mjery YA, et al. Frequency of UCP2 45-bp Ins/Del polymorphism in Saudi population from Jazan area and its association with autoimmune hypothyroidism UCP2 45-bp Ins/Del frequency in hypothyroidism. International journal of health sciences. 2020;14(4): 11–16.
- Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer, 2018.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research. 1988;16(3): 1215.
- Sánchez-Martínez R, Cruz-Gil S, García-Álvarez MS, Reglero G, Ramírez de Molina A. Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells. Scientific reports. 2017;7(1): 11143.
https://www.ncbi.nlm.nih.gov/snp/rs8086 - Donadelli M, Dando I, Fiorini C, Palmieri M. UCP2, a mitochondrial protein regulated at multiple levels. Cellular and molecular life sciences 2014;71(7): 1171–1190.
- Pecqueur C, Bui T, Gelly C, Hauchard J, Barbot C, Bouillaud F, et al. Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. FASEB journal. 2008;22(1):9–18.
- Esterbauer H, Schneitler C, Oberkofler H, Eben-bichler C, Paulweber B, Sandhofer F, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nature genetics. 2001;28(2): 178–183.
- Li J, Jiang R, Cong X, Zhao Y. UCP2 gene polymorphisms in obesity and diabetes, and the role of UCP2 in cancer. FEBS letters. 2019;593(18): 2525–2534.
- van Rossum CT, Hoebee B, Seidell JC, Bouchard C, van Baak MA, de Groot CP, et al. Genetic factors as predictors of weight gain in young adult Dutch men and women. International journal of obesity and related metabolic disorders. 2002;26(4):517–528.
- Gambino CM, Accardi G, Aiello A, Caruso C, Carru C, Gioia BG, et al. Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thickness. Minerva cardioangiologica. 2020;68(6):609–618.
- Stanzione R, Cotugno M, Forte M, Bianchi F, Marchitti S, Palomba NP, et al. Role of Uncoupling Protein 2 Gene Polymorphisms on the Risk of Ischemic Stroke in a Sardinian Population. Life (Basel, Switzerland). 2022;12(5):721.
- Marques D, Ferreira-Costa LR, Ferreira-Costa LL, Correa RDS, Borges AMP, Ito FR, et al. Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features. World journal of gastroenterology. 2017;23(37):6854–6867.
- Kuai XY, Ji ZY, Zhang HJ. Mitochondrial uncoupling protein 2 expression in colon cancer and its clinical significance. World journal of gastroenterology. 2010;16(45):5773–5778.
- Kyriazanos, I. D., Dhar, D. K., Rahman, M. A., Ohno, S., Kubota, H., Kohno, H., & Nagasue, N. Impact of uncoupling protein-2 expression on the prognosis of gastric adenocarcinoma patients. Digestive and liver disease. 2003;35(8):597–599.
- Paschke S, Jafarov S, Staib L, Kreuser ED, Maulbecker-Armstrong C, Roitman M, et al. Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. International journal of molecular sciences. 2018;19(9):2577.
- Mates IN, Jinga V, Csiki IE, Mates D, Dinu D, Constantin A, Jinga M. Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage. Journal of gastrointestinal and liver diseases. 2012;21(1):45–52.
- Srinivasan S, Clemens JA, Batra J. Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer? Crit Rev Clin Lab Sci. 2016;53(1):29–39.
DOI: https://doi.org/10.2478/bjmg-2025-00015 | Journal eISSN: 2199-5761
Language: English
Page range: 41 - 48
Published on: May 14, 2026
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 E Ajaj, D Cvetković, M Rašić, M Ristanović, J Petrović Šunderić, V Dragutinović, N Maksimović, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.